COVID-19 vaccine

iNCOVACC is the world’s first Intranasal vaccine for COVID to receive approval for the primary 2-dose schedule, and heterologous…

People in the 18-59 years' age group can get free precaution doses of the COVID vaccine at government vaccination centres under a…

Anjali Taneja, Associate Director, Science Policy Initiative, Ashoka University, emphasises that public-private partnerships and…

The study showed that the number of antibodies produced and protection offered by vaccination increased substantially after the…

Health Canada is updating the product monograph-or label-for the AstraZeneca and Covishield COVID-19 vaccines to add capillary…

The public health and social measures are a wide range of non-pharmaceutical interventions, both individual and societal, and are…

The study showed that post-vaccination infection (PVI) occurred in only 4.28 per cent of healthcare workers (HCWs) with no…

Need to build hospital infrastructure, human resources and ICU facility at the grass-root level; opportunity for private sector

The new vaccine, called pan-coronavirus vaccine, was found effective in protecting monkeys and mice

Conditions include one-dose vaccine effectiveness (efficacy) of 80 per cent or higher and vaccination rates of 0.1 per cent to 0.3…